Cure Forward Corp. — Form D
Cure Forward Corp. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2014-11-14. The offering totals $2.0M, of which $500K was reported sold. Industry: Other Technology.
Offering
- Filed: 2014-11-14
- Form: D
- Accession: 0001140361-14-042143
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $500K
- Remaining: $1.5M
- Investors: 1
- Date of first sale: 2014-10-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-228382
Issuer
- Name: Cure Forward Corp.
- CIK: 0001624526
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 263 SUMMER STREET, BOSTON, MA, 02210
- Phone: 650-463-4052
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Seth Harrison | Director | Redwood City, CA |
| Frank Ingari | Director | Portland, OR |
| Frank Ingari | Executive Officer | Portland, OR |
| Aaron Kantoff | Director | Rockville, MD |
| Stephanie Papes | Director | Portland, OR |
| Preston Brice | Director | Coral Gables, FL |
| Steve Hau | Executive Officer | Boston, MA |
| Martin Naley | Director | Cambridge, MA |
| Martin Naley | Executive Officer | Cambridge, MA |
| Lauren Farrell | Executive Officer | Cambridge, MA |
Other filings by this issuer (5)
More